18 Oct
|
Alexion, AstraZeneca Rare Disease
|
Toronto
18 Oct
Alexion, AstraZeneca Rare Disease
Toronto
Drives patient insights and strategy in rare diseases from drug development to commercialization, collaborating with stakeholders to improve patient access to medicines.
📌 Global Patient Insights & Solution (Gpis), Paths Strategic Partner - $146,108 - $191,766.8 A Year (Toronto)
🏢 Alexion, AstraZeneca Rare Disease
📍 Toronto